Key questions for perioperative chemotherapy in resectable lung cancer: not pre vs post, but who and what? [electronic resource]
- Oncology (Williston Park, N.Y.) May 2009
- 527, 532 p. digital
Publication Type: Journal Article; Comment
0890-9091
Antigens, Neoplasm--immunology Cancer Vaccines Carcinoma, Non-Small-Cell Lung--mortality Chemotherapy, Adjuvant ErbB Receptors--antagonists & inhibitors Erlotinib Hydrochloride Humans Lung Neoplasms--mortality Neoadjuvant Therapy Neoplasm Proteins--immunology Patient Selection Protein Kinase Inhibitors--therapeutic use Quinazolines--therapeutic use Randomized Controlled Trials as Topic